SCHEMBL6282519

SCHEMBL6282519

CCOC(=O)c1cn(CCc2ccccc2)c2occc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPK1 P28482 1/20 0.46
MAOB P27338 1/20 0.46
P2RX3 P56373 1/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRB2 P47870 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6282379 0.86 LMNA (0.48) TSHRTDP1MAPTSMN1; SMN2MAPK1
SCHEMBL6284441 0.84 LMNA (0.56) TSHRTDP1MAPTSMN1; SMN2MAPK1
SCHEMBL6278291 0.81 LMNA (0.47) TSHRTDP1MAPTSMN1; SMN2MAPK1
SCHEMBL6281429 0.80 MAOB (0.48) TSHRTDP1MAPTMAOBLMNA
SCHEMBL6281174 0.80 MAOB (0.49) TSHRTDP1MAPTMAOBLMNA
SCHEMBL6287389 0.76 ALDH1A1 (0.57) TSHRTDP1MAPTP2RX3LMNA
SCHEMBL4659798 0.74 KMT2A (0.54) TSHRTDP1MAPTMAPK1P2RX3
SCHEMBL30292037 0.74 TP53 (0.54) TSHRTDP1P2RX3LMNAALDH1A1
SCHEMBL6281585 0.73 HPGD (0.47) TSHRTDP1MAPTMAPK1MAOB
SCHEMBL6285810 0.73 ADRB2 (0.45) TSHRTDP1MAPTMAOBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6878705-B2 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents PFIZER (US) 2005-04-12 US disclosed
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS IL4, ZC3HAV1, IRF3 TSHR 3637/4885TDP1 1612/4885MAPT 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.